Search
Filter Results
Displaying 551–560 of 723 for “Visions 2020”
-
Feb 21, 2023
Foundation Fighting Blindness to Host their Spring VisionWalks
These VisionWalk events taking place this spring will raise awareness and fund research finding treatments and cures for blinding retinal diseases.
-
Jan 9, 2023
Fearless Sister Duo Finding Hope
April LuFriu and Melissa Escobio are sisters and best friends who do just about everything together, including having retinitis pigmentosa (RP).
-
Jan 6, 2023
The Retinal Degeneration Fund invests in a $78M Series B for Perceive Biotherapeutics
The investment supports the clinical development of two novel programs, both with the aim of being protective against vision loss.
-
Jan 3, 2023
Opus Genetics Acquires Rights to Gene Therapies for BEST1 and RP (RHO)
The company plans to seek clinical trial authorization for the BEST1 gene therapy during the second half of 2023
-
Dec 2, 2022
Eye on the Cure Podcast – Episode 36: Sue Bramhall
December 2, 2022. Host Ben Shaberman interviews Sue Bramhall.
-
Nov 10, 2022
Uni-Rare Study will improve clinical understanding of more IRDs and boost development of potential therapies.
-
Nov 4, 2022
Eye on the Cure Podcast – Episode 34: LambdaVision
November 4, 2022. Ben Shaberman talks with LambdaVision’s Nicole Wagner, PhD, and Jordan Greco, PhD.
-
My name is Terry Super. As a Professional Engineer, my career was defined by technical and left-brained stuff. Today, I’m semi-retired and have been relaxing by doing some creative and right-brained stuff - oil painting.
-
Jun 20, 2022
The newly approved drug reduces the pathologic hunger associated with BBS
-
May 12, 2022
Opus Genetics Appoints Jennifer Hunt Chief Development Officer
Biopharma clinical development veteran to propel Opus’ AAV-based gene therapies for inherited retinal diseases toward patients.